The Wall Street Analyst Forum's 17th Annual Analyst Conference to Webcast OrthoLogic Presentation
November 22 2005 - 9:44AM
PR Newswire (US)
TEMPE, Ariz., Nov. 22 /PRNewswire-FirstCall/ -- OrthoLogic Corp.
(NASDAQ:OLGC) announced today that management will provide an
overview of the Company and its lead compound for tissue and bone
healing, Chrysalin(R), at The Wall Street Analyst Forum's 17th
Annual Analyst Conference. The presentation will be delivered at
12:30 p.m. EST on Tuesday, November 29, 2005 from The Roosevelt
Hotel in New York. The presentation will be webcast live and may be
accessed by visiting the Investors section of the Company's
website, http://www.orthologic.com/. It will be archived for 30
days. OrthoLogic is a biotechnology company focused on the
development and commercialization of the novel synthetic peptide
Chrysalin(R) (TP508) in three lead indications, all of which
represent areas of significant unmet medical need -- fracture
repair, diabetic foot ulcer healing and cartilage defect repair.
Based on the Company's pioneering scientific research of the
natural healing cascade, OrthoLogic has become the leading company
focused on tissue and bone repair. OrthoLogic is committed to
developing a pipeline of novel peptides and other molecules aimed
at helping patients with equally under-served conditions. The
Company maintains exclusive worldwide rights for Chrysalin.
OrthoLogic's corporate headquarters are in Tempe, Arizona. For more
information, please visit the Company's website:
http://www.orthologic.com/. DATASOURCE: OrthoLogic Corp. CONTACT:
Media, Lauren Tortorete of Biosector 2, +1-212-845-5609; or
Investors, Melanie Friedman of Stern Investor Relations,
+1-212-362-1200, both for OrthoLogic Corp. Web site:
http://www.orthologic.com/
Copyright
Orthologic (MM) (NASDAQ:OLGC)
Historical Stock Chart
From Jul 2024 to Aug 2024
Orthologic (MM) (NASDAQ:OLGC)
Historical Stock Chart
From Aug 2023 to Aug 2024